Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035688

Director acquired 3,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NARACHI MICHAEL Director 2023-06-07 Grant or award +3,860 21,605 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
NARACHI MICHAEL Director 2023-06-07 Grant or award · Common Stock +7,110 7,110 D: show line 2 in the form
Loading xslF345X04/doc4.xml…